Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2022-05-11 | Mr. Fraser has served as President and Chief Executive Officer, or CEO, and a member of the Board since February 1, 2016. He brings over 30 years of experience as a leader in drug development, fundraising, business development and commercial operations in building biopharmaceutical and device businesses for startups as well as larger companies. Mr. Fraser received his B.S. degree in Public Administration from Slippery Rock University of Pennsylvania. |
| 2023-01-10 | Craig E. Fraser Director, President and Chief Executive Officer |
| 2023-06-30 | Mr. Fraser received his B.S. degree in Public Administration from Slippery Rock University of Pennsylvania. |
| 2024-03-12 | Craig E. Fraser - Chairman of the Board, President and Chief Executive Officer; includes 9,788 shares of common stock, 981 restricted stock units, and options to purchase 18,290 shares. |
| 2024-09-03 | Mr. Fraser received his B.S. degree in Public Administration from Slippery Rock University of Pennsylvania. |
| 2025-01-08 | Craig E. Fraser (1) |
Data sourced from SEC filings. Last updated: 2025-10-12